Phase 2 trials already showed up to 24.2% body weight reduction at 48 weeks, making it the most potent weight loss compound in clinical development
However, the modest effect does not negate the potential value of these drugs, especially for conditions where few effective treatment options exist, for example, dementia, Al-Aly said
Streeper RS, Henriksen EJ, Jacob S, Hokama JY, Fogt DL, Tritschler HJ
Quality sleep is essential for overall health
To qualify for a GLP-1 prescribed for weight loss, you need a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related comorbidity, and no contraindications in your medical history
In the clinical trial of participants with type 2 diabetes, HbA1c reductions of -1.88% to -2.02% were observed at the 8 mg and 12 mg doses by 24 weeks